In vivo effects of COPP protocol on onco- and suppressor gene expression in a 'follow up study'.
In vivo investigation of onco or suppressor genes may provide new information concerning chemical carcinogenesis. In earlier studies we illustrated the carcinogenic potential of COPP chemotherapeutical protocol in "long term" experiments. Elevated expression of oncogenes was shown as soon as 24 hours after treatment in CBA/Ca inbred mice, in "short term" experiments. Now we present the results of the follow-up study dealing with the carcinogenic effect of COPP. The genes most frequently involved were N-ras and p53, with the thymus being the target organ of COPP.
Ember
I
I
Department of Preventive Medicine, University Medical School of Pécs, Hungary.
Kiss
I
I
Raposa
T
T
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D015870:Gene Expression / Q000187:drug effects*; D016259:Genes, myc; D016158:Genes, p53; D011905:Genes, ras; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D011344:Procarbazine; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone